J&J prepares to face ruling in first Pinnacle hip implant trial

Johnson & Johnson ($JNJ) is facing allegations that the company, in an effort to preserve billions in profit, ignored overwhelming evidence that its Pinnacle hip implants were dangerous. A Montana woman brought her case to a Dallas, TX, federal court, with closing arguments heard on Oct. 20. She was suing after the device leaked cobalt and chromium material into her bloodstream, causing an infection that required surgical removal. The case brought against the company is the first of more than 6,000 to come regarding the device. A 9-person jury began deliberations yesterday. If found guilty of fraud or acting with malice in its design or handling of the implants, J&J could face a punitive damages judgment. More

Suggested Articles

InterVene secured $15 million to validate its catheter-based treatment for correcting failed one-way valves in the veins of the legs.

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.